ISRCTN ISRCTN12187583
DOI https://doi.org/10.1186/ISRCTN12187583
Secondary identifying numbers RBG 00XX77
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
09/12/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nigel Sturrock
Scientific

Consultant Physician
Nottingham City Hospital NHS Trust
Hucknall Road
Nottingham
NG5 1PB
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesTo assess the effectiveness of a simple treatment algorithm in primary care in attaining the recommended blood pressure in patients with type 2 diabetes compared to usual practice. To assess the cost-effectiveness of the algorithm for improving blood pressure control in these patients.

Assuming 40% of diabetics have a blood pressure of <140/80 an intracluster correlation coefficient (ICC) of 0.02 and an average cluster size of 45 type 2 diabetics per practice. Based on 80% power and 5% two-sided significance level 388 participants would be required in each arm of the study.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNutritional, metabolic and endocrine diseases: Diabetes
InterventionNot provided at time of registration
Intervention typeOther
Primary outcome measureProportion of participants who have achieved good blood pressure control defined as reaching the recommended level of <140/80.
Secondary outcome measuresChange in blood pressure from baseline, attendance at hypertension review appointments and patient satisfaction with the care received. Both measures will be assessed at 12 months post recruitment to the trial.
Overall study start date01/03/2001
Completion date28/02/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants388 participants would be required in each arm of the study.
Key inclusion criteriaThe study population will comprise all patients with type 2 diabetes on the lists of participating general practitioners who give informed consent to participate in the study.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/03/2001
Date of final enrolment28/02/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Consultant Physician
Nottingham
NG5 1PB
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive Trent (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2007 Yes No